Header Logo

Connection

THOMAS KOSTEN to Opioid-Related Disorders

Back to Details
This is a "connection" page, showing publications THOMAS KOSTEN has written about Opioid-Related Disorders.
THOMAS KOSTEN
Connection Strength
14.661
Opioid-Related Disorders
  1. Moderation of buprenorphine therapy for cocaine dependence efficacy by variation of the Prodynorphin gene. Eur J Clin Pharmacol. 2022 Jun; 78(6):965-973.
    View in: PubMed
    Score: 0.576
  2. The Hidden Epidemic of Opioid Overdoses During the Coronavirus Disease 2019 Pandemic. JAMA Psychiatry. 2021 06 01; 78(6):585-586.
    View in: PubMed
    Score: 0.547
  3. Cognitive performance of patients with opioid use disorder transitioned to extended-release injectable naltrexone from buprenorphine: Post hoc analysis of exploratory results of a phase 3 randomized controlled trial. Addict Behav. 2020 12; 111:106538.
    View in: PubMed
    Score: 0.513
  4. Keeping Up with Clinical Advances: Opioid Use Disorder. CNS Spectr. 2019 08; 24(S1):14-24.
    View in: PubMed
    Score: 0.482
  5. Neurobiology of Opioid Use Disorder and Comorbid Traumatic Brain Injury. JAMA Psychiatry. 2018 06 01; 75(6):642-648.
    View in: PubMed
    Score: 0.444
  6. Opioid Use Disorder After Self-medicating Pain From Traumatic Brain Injury. JAMA Psychiatry. 2018 06 01; 75(6):649-650.
    View in: PubMed
    Score: 0.444
  7. Antagonists in the medical management of opioid use disorders: Historical and existing treatment strategies. Am J Addict. 2018 04; 27(3):177-187.
    View in: PubMed
    Score: 0.439
  8. Update on pharmacotherapy for treatment of opioid use disorder. Expert Opin Pharmacother. 2016 Dec; 17(17):2307-2318.
    View in: PubMed
    Score: 0.397
  9. Buprenorphine Prescribing: To Expand or Not to Expand. J Psychiatr Pract. 2016 05; 22(3):183-92.
    View in: PubMed
    Score: 0.384
  10. Buprenorphine in the treatment of opioid addiction: opportunities, challenges and strategies. Expert Opin Pharmacother. 2014 Oct; 15(15):2263-75.
    View in: PubMed
    Score: 0.342
  11. Naltrexone with or without guanfacine for preventing relapse to opiate addiction in St.-Petersburg, Russia. Drug Alcohol Depend. 2013 Oct 01; 132(3):674-80.
    View in: PubMed
    Score: 0.313
  12. Pharmacogenetic randomized trial for cocaine abuse: disulfiram and dopamine ?-hydroxylase. Biol Psychiatry. 2013 Feb 01; 73(3):219-24.
    View in: PubMed
    Score: 0.297
  13. The potential of pharmacogenomics to treat drug addiction. Pharmacogenomics. 2009 Dec; 10(12):1883-6.
    View in: PubMed
    Score: 0.246
  14. Opioid dependence treatment: options in pharmacotherapy. Expert Opin Pharmacother. 2009 Aug; 10(11):1727-40.
    View in: PubMed
    Score: 0.241
  15. Efficacy of opiate maintenance therapy and adjunctive interventions for opioid dependence with comorbid cocaine use disorders: A systematic review and meta-analysis of controlled clinical trials. Am J Drug Alcohol Abuse. 2009; 35(5):339-49.
    View in: PubMed
    Score: 0.231
  16. New hot topics sections: 1. China's new march forward in addiction treatment: methadone for the masses. 2. Issues in formulating DSM V. Am J Drug Alcohol Abuse. 2008; 34(2):123-6.
    View in: PubMed
    Score: 0.216
  17. Pharmacogenetic treatments for drug addiction: alcohol and opiates. Am J Drug Alcohol Abuse. 2008; 34(4):355-81.
    View in: PubMed
    Score: 0.216
  18. Effects of lofexidine on stress-induced and cue-induced opioid craving and opioid abstinence rates: preliminary findings. Psychopharmacology (Berl). 2007 Mar; 190(4):569-74.
    View in: PubMed
    Score: 0.200
  19. Identifying compounds to treat opiate use disorder by leveraging multi-omic data integration and multiple drug repurposing databases. Transl Psychiatry. 2025 Nov 21; 15(1):528.
    View in: PubMed
    Score: 0.186
  20. Efficacy of dose and contingency management procedures in LAAM-maintained cocaine-dependent patients. Drug Alcohol Depend. 2005 Aug 01; 79(2):157-65.
    View in: PubMed
    Score: 0.182
  21. What are America's opportunities for harm reduction strategies in opiate dependence? Am J Addict. 2005 Jul-Sep; 14(4):307-10.
    View in: PubMed
    Score: 0.181
  22. Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence. Am J Psychiatry. 2005 Feb; 162(2):340-9.
    View in: PubMed
    Score: 0.176
  23. Consensus statement on office-based treatment of opioid dependence using buprenorphine. J Subst Abuse Treat. 2004 Sep; 27(2):153-9.
    View in: PubMed
    Score: 0.171
  24. Vaccines as Immunotherapies for Substance Use Disorders. Am J Psychiatry. 2024 May 01; 181(5):362-371.
    View in: PubMed
    Score: 0.167
  25. Combating opiate dependence: a comparison among the available pharmacological options. Expert Opin Pharmacother. 2004 Apr; 5(4):713-25.
    View in: PubMed
    Score: 0.166
  26. Buprenorphine for office-based practice: consensus conference overview. Am J Addict. 2004; 13 Suppl 1:S1-7.
    View in: PubMed
    Score: 0.164
  27. D-cycloserine-Naloxone interactions in opioid-dependent humans under a novel-response naloxone discrimination procedure. Exp Clin Psychopharmacol. 2003 Aug; 11(3):237-46.
    View in: PubMed
    Score: 0.159
  28. Comorbid major depressive disorder as a prognostic factor in cocaine-abusing buprenorphine-maintained patients treated with desipramine and contingency management. Am J Drug Alcohol Abuse. 2003 Aug; 29(3):497-514.
    View in: PubMed
    Score: 0.159
  29. Clinical Trial Design Challenges and Opportunities for Emerging Treatments for Opioid Use Disorder: A Review. JAMA Psychiatry. 2023 01 01; 80(1):84-92.
    View in: PubMed
    Score: 0.153
  30. The effect of a methadone-initiated memory reconsolidation updating procedure in opioid use disorder: A translational study. EBioMedicine. 2022 Nov; 85:104283.
    View in: PubMed
    Score: 0.150
  31. The neurobiology of opioid dependence: implications for treatment. Sci Pract Perspect. 2002 Jul; 1(1):13-20.
    View in: PubMed
    Score: 0.147
  32. Ketoconazole increases cocaine and opioid use in methadone maintained patients. Drug Alcohol Depend. 2002 Apr 01; 66(2):173-80.
    View in: PubMed
    Score: 0.145
  33. Rationale, design and methods of VA-BRAVE: a randomized comparative effectiveness trial of two formulations of buprenorphine for treatment of opioid use disorder in veterans. Addict Sci Clin Pract. 2022 01 31; 17(1):6.
    View in: PubMed
    Score: 0.143
  34. The Lexington narcotic farm. Am J Psychiatry. 2002 Jan; 159(1):22.
    View in: PubMed
    Score: 0.142
  35. Utility of crossover designs in clinical trials: efficacy of desipramine vs. placebo in opioid-dependent cocaine abusers. Am J Addict. 2002; 11(2):111-23.
    View in: PubMed
    Score: 0.142
  36. Buprenorphine for opiate addiction: potential economic impact. Drug Alcohol Depend. 2001 Aug 01; 63(3):253-62.
    View in: PubMed
    Score: 0.138
  37. The OPRD1 rs678849 variant influences outcome of disulfiram treatment for cocaine dependency in methadone-maintained patients. Psychiatr Genet. 2021 06 01; 31(3):88-94.
    View in: PubMed
    Score: 0.137
  38. Thrice-weekly versus daily buprenorphine maintenance. Biol Psychiatry. 2000 Jun 15; 47(12):1072-9.
    View in: PubMed
    Score: 0.128
  39. Neurobiological adaptations to psychostimulants and opiates as a basis of treatment development. Ann N Y Acad Sci. 2000; 909:51-87.
    View in: PubMed
    Score: 0.124
  40. Current concepts in pharmacotherapy of substance abuse. Curr Psychiatry Rep. 1999 Dec; 1(2):172-8.
    View in: PubMed
    Score: 0.123
  41. Desipramine in opioid-dependent cocaine abusers maintained on buprenorphine vs methadone. Arch Gen Psychiatry. 1999 Sep; 56(9):812-20.
    View in: PubMed
    Score: 0.121
  42. Lofexidine in Combination With Oral Naltrexone for Opioid Use Disorder Relapse Prevention: A Pilot Randomized, Double-Blind, Placebo-Controlled Study. Am J Addict. 2019 11; 28(6):480-488.
    View in: PubMed
    Score: 0.121
  43. Review article: Effective management of opioid withdrawal symptoms: A gateway to opioid dependence treatment. Am J Addict. 2019 02; 28(2):55-62.
    View in: PubMed
    Score: 0.116
  44. Hydromorphone-naloxone combinations in opioid-dependent humans under a naloxone novel-response discrimination procedure. Exp Clin Psychopharmacol. 1998 May; 6(2):169-78.
    View in: PubMed
    Score: 0.110
  45. A comprehensive pharmacologic-psychosocial treatment program for HIV-seropositive cocaine- and opioid-dependent patients. Preliminary findings. J Subst Abuse Treat. 1998 May-Jun; 15(3):261-5.
    View in: PubMed
    Score: 0.110
  46. Outpatient transition to extended-release injectable naltrexone for patients with opioid use disorder: A phase 3 randomized trial. Drug Alcohol Depend. 2018 06 01; 187:171-178.
    View in: PubMed
    Score: 0.110
  47. Rapid and ultrarapid opioid detoxification techniques. JAMA. 1998 Jan 21; 279(3):229-34.
    View in: PubMed
    Score: 0.108
  48. Prognostic factors in Buprenorphine- versus methadone-maintained patients. J Nerv Ment Dis. 1998 Jan; 186(1):35-43.
    View in: PubMed
    Score: 0.108
  49. Effect of LAAM dose on opiate use in opioid-dependent patients. A pilot study. Am J Addict. 1998; 7(4):272-82.
    View in: PubMed
    Score: 0.108
  50. Association between self-report of cognitive impairment, HIV status, and cocaine use in a sample of cocaine-dependent methadone-maintained patients. Addict Behav. 1997 Sep-Oct; 22(5):599-611.
    View in: PubMed
    Score: 0.105
  51. Increased habenular connectivity in opioid users is associated with an a5 subunit nicotinic receptor genetic variant. Am J Addict. 2017 Oct; 26(7):751-759.
    View in: PubMed
    Score: 0.105
  52. Buprenorphine vs methadone maintenance treatment for concurrent opioid dependence and cocaine abuse. Arch Gen Psychiatry. 1997 Aug; 54(8):713-20.
    View in: PubMed
    Score: 0.105
  53. Guanine nucleotide binding proteins in opioid-dependent patients. Biol Psychiatry. 1997 Jan 15; 41(2):130-4.
    View in: PubMed
    Score: 0.101
  54. Pemoline for the treatment of cocaine dependence in methadone-maintained patients. J Psychoactive Drugs. 1996 Jul-Sep; 28(3):301-4.
    View in: PubMed
    Score: 0.097
  55. Effects of ethnicity on low-dose opiate stabilization. J Subst Abuse Treat. 1995 Mar-Apr; 12(2):111-6.
    View in: PubMed
    Score: 0.089
  56. Reduction of opiate withdrawal-like symptoms by cocaine abuse during methadone and buprenorphine maintenance. Am J Drug Alcohol Abuse. 1994 Nov; 20(4):445-58.
    View in: PubMed
    Score: 0.087
  57. Buprenorphine: duration of blockade of effects of intramuscular hydromorphone. Drug Alcohol Depend. 1994 Apr; 35(2):141-9.
    View in: PubMed
    Score: 0.083
  58. Cocaine abuse in methadone maintenance programs: integrating pharmacotherapy with psychosocial interventions. J Psychoactive Drugs. 1994 Apr-Jun; 26(2):137-46.
    View in: PubMed
    Score: 0.083
  59. Randomized clinical trial of disulfiram for cocaine dependence or abuse during buprenorphine treatment. Drug Alcohol Depend. 2014 Mar 01; 136:36-42.
    View in: PubMed
    Score: 0.082
  60. Buprenorphine versus methadone maintenance for opioid dependence. J Nerv Ment Dis. 1993 Jun; 181(6):358-64.
    View in: PubMed
    Score: 0.079
  61. Pharmacotherapy for cocaine-abusing methadone-maintained patients using amantadine or desipramine. Arch Gen Psychiatry. 1992 Nov; 49(11):894-8.
    View in: PubMed
    Score: 0.075
  62. Opioid detoxification and naltrexone induction strategies: recommendations for clinical practice. Am J Drug Alcohol Abuse. 2012 May; 38(3):187-99.
    View in: PubMed
    Score: 0.072
  63. Phase II clinical trials of buprenorphine: detoxification and induction onto naltrexone. NIDA Res Monogr. 1992; 121:101-19.
    View in: PubMed
    Score: 0.071
  64. The predictive validity of the dependence syndrome in opiate abusers. Am J Drug Alcohol Abuse. 1992; 18(2):145-56.
    View in: PubMed
    Score: 0.071
  65. Buprenorphine for cocaine and opiate dependence. Psychopharmacol Bull. 1992; 28(1):15-9.
    View in: PubMed
    Score: 0.071
  66. Alcoholism and depressive disorders in opioid addicts and their family members. Compr Psychiatry. 1991 Nov-Dec; 32(6):521-7.
    View in: PubMed
    Score: 0.070
  67. Gender differences in the specificity of alcoholism transmission among the relatives of opioid addicts. J Nerv Ment Dis. 1991 Jul; 179(7):392-400.
    View in: PubMed
    Score: 0.069
  68. Buprenorphine: beyond methadone? Hosp Community Psychiatry. 1991 Apr; 42(4):347-9.
    View in: PubMed
    Score: 0.068
  69. Depressive symptoms during buprenorphine treatment of opioid abusers. J Subst Abuse Treat. 1990; 7(1):51-4.
    View in: PubMed
    Score: 0.062
  70. Cocaine vaccine for the treatment of cocaine dependence in methadone-maintained patients: a randomized, double-blind, placebo-controlled efficacy trial. Arch Gen Psychiatry. 2009 Oct; 66(10):1116-23.
    View in: PubMed
    Score: 0.061
  71. Rapid detoxification from opioid dependence. Am J Psychiatry. 1989 Oct; 146(10):1349.
    View in: PubMed
    Score: 0.061
  72. Naloxone challenge as a biological predictor of treatment outcome in opiate addicts. Am J Drug Alcohol Abuse. 1989; 15(4):355-66.
    View in: PubMed
    Score: 0.058
  73. Buprenorphine treatment of cocaine abuse. NIDA Res Monogr. 1989; 95:461.
    View in: PubMed
    Score: 0.058
  74. Severity of precipitated opiate withdrawal predicts drug dependence by DSM-III-R criteria. Am J Drug Alcohol Abuse. 1989; 15(3):237-50.
    View in: PubMed
    Score: 0.058
  75. Personality disorders in opiate addicts show prognostic specificity. J Subst Abuse Treat. 1989; 6(3):163-8.
    View in: PubMed
    Score: 0.058
  76. Preliminary study of buprenorphine and bupropion for opioid-dependent smokers. Am J Addict. 2008 Jul-Aug; 17(4):287-92.
    View in: PubMed
    Score: 0.056
  77. Antecedents and consequences of cocaine abuse among opioid addicts. A 2.5-year follow-up. J Nerv Ment Dis. 1988 Mar; 176(3):176-81.
    View in: PubMed
    Score: 0.055
  78. Suicidality among opioid addicts: 2.5 year follow-up. Am J Drug Alcohol Abuse. 1988; 14(3):357-69.
    View in: PubMed
    Score: 0.054
  79. A preliminary study of desipramine in the treatment of cocaine abuse in methadone maintenance patients. J Clin Psychiatry. 1987 Nov; 48(11):442-4.
    View in: PubMed
    Score: 0.053
  80. Clinical efficacy of citalopram alone or augmented with bupropion in methadone-stabilized patients. Am J Addict. 2007 May-Jun; 16(3):187-94.
    View in: PubMed
    Score: 0.051
  81. A 2.5-year follow-up of cocaine use among treated opioid addicts. Have our treatments helped? Arch Gen Psychiatry. 1987 Mar; 44(3):281-4.
    View in: PubMed
    Score: 0.051
  82. Source of income as a predictor in opioid addicts: 2.5 year follow-up. NIDA Res Monogr. 1987; 76:196-9.
    View in: PubMed
    Score: 0.050
  83. The dependence syndrome across different psychoactive substances: revised DSM-III. NIDA Res Monogr. 1987; 76:255-8.
    View in: PubMed
    Score: 0.050
  84. Predictors of 2.5-year outcome in opioid addicts: pretreatment source of income. Am J Drug Alcohol Abuse. 1987; 13(1-2):19-32.
    View in: PubMed
    Score: 0.050
  85. Relationship of marital structure and interactions to opiate abuse relapse. Am J Drug Alcohol Abuse. 1987; 13(4):387-99.
    View in: PubMed
    Score: 0.050
  86. Multidimensionality and prediction of treatment outcome in opioid addicts: 2.5-year follow-up. Compr Psychiatry. 1987 Jan-Feb; 28(1):3-13.
    View in: PubMed
    Score: 0.050
  87. Pharmacotherapeutic environments for substance use disorders. Am J Drug Alcohol Abuse. 2007; 33(5):627-9.
    View in: PubMed
    Score: 0.050
  88. Psychopathology in opioid addicts. Psychiatr Clin North Am. 1986 Sep; 9(3):515-32.
    View in: PubMed
    Score: 0.049
  89. Diagnosing depression with the DST and TRH in cocaine and opioid abusers. J Subst Abuse Treat. 1986; 3(1):47-9.
    View in: PubMed
    Score: 0.047
  90. The effect of multiple family therapy on addict family functioning: a pilot study. Adv Alcohol Subst Abuse. 1986; 5(3):51-62.
    View in: PubMed
    Score: 0.047
  91. Cocaine abuse among opioid addicts: demographic and diagnostic factors in treatment. Am J Drug Alcohol Abuse. 1986; 12(1-2):1-16.
    View in: PubMed
    Score: 0.047
  92. A 2.5 year follow-up of treatment retention and reentry among opioid addicts. J Subst Abuse Treat. 1986; 3(3):181-9.
    View in: PubMed
    Score: 0.047
  93. Parental alcoholism in opioid addicts. J Nerv Ment Dis. 1985 Aug; 173(8):461-9.
    View in: PubMed
    Score: 0.046
  94. Ethnic and gender differences among opiate addicts. Int J Addict. 1985 Aug; 20(8):1143-62.
    View in: PubMed
    Score: 0.046
  95. Comparison of clinician ratings to self reports of withdrawal during clonidine detoxification of opiate addicts. Am J Drug Alcohol Abuse. 1985; 11(1-2):1-10.
    View in: PubMed
    Score: 0.044
  96. Strategies to improve compliance with narcotic antagonists. Am J Drug Alcohol Abuse. 1984; 10(2):249-66.
    View in: PubMed
    Score: 0.041
  97. Perceived marital and family environment of opiate addicts. Am J Drug Alcohol Abuse. 1984; 10(4):491-501.
    View in: PubMed
    Score: 0.041
  98. Challenges in increasing access to buprenorphine treatment for opiate addiction. Am J Addict. 2004; 13 Suppl 1:S8-16.
    View in: PubMed
    Score: 0.041
  99. The relationship of the Maudsley Personality Inventory to depression in addicts. Compr Psychiatry. 1983 Nov-Dec; 24(6):535-42.
    View in: PubMed
    Score: 0.040
  100. Family denial as a prognostic factor in opiate addict treatment outcome. J Nerv Ment Dis. 1983 Oct; 171(10):611-6.
    View in: PubMed
    Score: 0.040
  101. Prediction of treatment outcome by baseline urine cocaine results and self-reported cocaine use for cocaine and opioid dependence. Am J Drug Alcohol Abuse. 2003; 29(4):713-27.
    View in: PubMed
    Score: 0.038
  102. DSM-III personality disorders in opiate addicts. Compr Psychiatry. 1982 Nov-Dec; 23(6):572-81.
    View in: PubMed
    Score: 0.038
  103. Yohimbine-induced withdrawal and anxiety symptoms in opioid-dependent patients. Biol Psychiatry. 2002 Apr 15; 51(8):642-51.
    View in: PubMed
    Score: 0.036
  104. Methadone patients exhibit increased startle and cortisol response after intravenous yohimbine. Psychopharmacology (Berl). 2001 Mar; 154(3):274-81.
    View in: PubMed
    Score: 0.034
  105. Effect of opioid dependence pharmacotherapies on zidovudine disposition. Am J Addict. 2001; 10(4):296-307.
    View in: PubMed
    Score: 0.033
  106. A randomized controlled trial of auricular acupuncture for cocaine dependence. Arch Intern Med. 2000 Aug 14-28; 160(15):2305-12.
    View in: PubMed
    Score: 0.032
  107. When is less treatment better? The role of social anxiety in matching methadone patients to psychosocial treatments. J Consult Clin Psychol. 1998 Dec; 66(6):924-31.
    View in: PubMed
    Score: 0.029
  108. Decreased digital flow persists after the abatement of cocaine-induced hemodynamic stimulation. Anesth Analg. 1997 Jan; 84(1):46-50.
    View in: PubMed
    Score: 0.025
  109. Sustained-release methylphenidate for cognitive impairment in HIV-1-infected drug abusers: a pilot study. J Neuropsychiatry Clin Neurosci. 1997; 9(1):29-36.
    View in: PubMed
    Score: 0.025
  110. Opiate dependence and withdrawal: preliminary assessment using single photon emission computerized tomography (SPECT). Am J Drug Alcohol Abuse. 1995 Feb; 21(1):47-63.
    View in: PubMed
    Score: 0.022
  111. Baclofen-assisted detoxification from opiates. A pilot study. J Subst Abuse Treat. 1992; 9(2):139-42.
    View in: PubMed
    Score: 0.018
  112. Treatment of dual diagnosis patients: a relapse prevention group approach. J Subst Abuse Treat. 1992; 9(4):305-9.
    View in: PubMed
    Score: 0.018
  113. Pharmacological blocking agents for treating substance abuse. J Nerv Ment Dis. 1991 Oct; 179(10):583-92.
    View in: PubMed
    Score: 0.017
  114. Psychiatric disorders in relatives of probands with opiate addiction. Arch Gen Psychiatry. 1991 Jan; 48(1):33-42.
    View in: PubMed
    Score: 0.017
  115. Desipramine and its 2-hydroxy metabolite in patients taking or not taking methadone. Am J Psychiatry. 1990 Oct; 147(10):1379-80.
    View in: PubMed
    Score: 0.016
  116. Mazindol treatment of cocaine abuse. A double-blind investigation. NIDA Res Monogr. 1990; 105:514.
    View in: PubMed
    Score: 0.015
  117. The dependence syndrome concept as applied to alcohol and other substances of abuse. Recent Dev Alcohol. 1990; 8:47-68.
    View in: PubMed
    Score: 0.015
  118. Role of opioid antagonists in treating intravenous cocaine abuse. Life Sci. 1989; 44(13):887-92.
    View in: PubMed
    Score: 0.014
  119. Substance-use disorders in DSM-III-R. Evidence for the dependence syndrome across different psychoactive substances. Br J Psychiatry. 1987 Dec; 151:834-43.
    View in: PubMed
    Score: 0.013
  120. Treatment of patients with substance use disorders, second edition. American Psychiatric Association. Am J Psychiatry. 2007 Apr; 164(4 Suppl):5-123.
    View in: PubMed
    Score: 0.013
  121. The antecedents and benefits of achieving abstinence in opioid addicts: a 2.5-year follow-up study. Am J Drug Alcohol Abuse. 1987; 13(3):213-29.
    View in: PubMed
    Score: 0.013
  122. Long-term changes in current psychiatric diagnoses of treated opiate addicts. Compr Psychiatry. 1986 Sep-Oct; 27(5):480-98.
    View in: PubMed
    Score: 0.012
  123. A 2.5-year follow-up of short-term interpersonal psychotherapy in methadone-maintained opiate addicts. Compr Psychiatry. 1986 May-Jun; 27(3):201-10.
    View in: PubMed
    Score: 0.012
  124. Isradipine and dextromethorphan in methadone-maintained humans under a naloxone discrimination procedure. Eur J Pharmacol. 2004 May 03; 491(2-3):157-68.
    View in: PubMed
    Score: 0.010
  125. Concurrent validity of the addiction severity index. J Nerv Ment Dis. 1983 Oct; 171(10):606-10.
    View in: PubMed
    Score: 0.010
  126. Acupuncture for the treatment of cocaine addiction. Investigation of a needle puncture control. J Subst Abuse Treat. 1995 May-Jun; 12(3):195-205.
    View in: PubMed
    Score: 0.006
  127. Alprazolam and benzodiazepine dependence. J Clin Psychiatry. 1993 Oct; 54 Suppl:64-75; discussion 76-7.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.